Abstract: A Higgsless electroweak theory may be populated by spin-1 resonances around E similar to 1 TeV as a consequence of a new strong interacting sector, frequently proposed as a tool to smear the high-energy behaviour of scattering amplitudes, for instance, elastic gauge boson scattering. Information on those resonances, if they exist, must be contained in the low-energy couplings of the electroweak chiral effective theory. Using the facts that: i) the scattering of longitudinal gauge bosons, W-L, Z(L), can be well described in the high-energy region (E >> M-W) by the scattering of the corresponding Goldstone bosons (equivalence theorem) and ii) the zeros of the scattering amplitude carry the information on the heavier spectrum that has been integrated out; we employ the O(p(4)) electroweak chiral Lagrangian to identify the parameter space region of the low-energy couplings where vector resonances may arise. An estimate of their masses is also provided by our method.

Abstract: PURPOSE: The purpose of this work was to evaluate whether the delivered dose to the skin surface and at the prescription depth when using a Freiburg flap applicator is in agreement with the one predicted by the treatment planning system (TPS) using the TG-43 dose-calculation formalism. METHODS AND MATERIALS: Monte Carlo (MC) simulations and radiochromic film measurements have been performed to obtain dose distributions with the source located at the center of one of the spheres and between two spheres. Primary and scatter dose contributions were evaluated to understand the role played by the scatter component. A standard treatment plan was generated using MC- and TG-43-based TPS applying the superposition principle. RESULTS: The MC model has been validated by performing additional simulations in the same conditions but transforming air and Freiburg flap materials into water to match TG-43 parameters. Both dose distributions differ less than 1%. Scatter defect compared with TG-43 data is up to 15% when the source is located at the center of the sphere and up to 25% when the source is between two spheres. Maximum deviations between TPS- and MC-based distributions are of 5%. CONCLUSIONS: The deviations in the TG-43-based dose distributions for a standard treatment plan with respect to the MC dose distribution calculated taking into account the composition and shape of the applicator and the surrounding air are lower than 5%. Therefore, this study supports the validity of the TPS used in clinical practice. (C) 2012 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Abstract: A search for flavour changing neutral current (FCNC) processes in top-quark decays by the ATLAS Collaboration is presented. Data collected from pp collisions at the LHC at a centre-of-mass energy of root s = 7 TeV during 2011, corresponding to an integrated luminosity of 2.1 fb(-1), were used. A search was performed for top-quark pair-production events, with one top quark decaying through the t -> Zq FCNC (q = u, c) channel, and the other through the Standard Model dominant mode t -> Wb. Only the decays of the Z boson to charged leptons and leptonic W-boson decays were considered as signal. Consequently, the final-state topology is characterised by the presence of three isolated charged leptons, at least two jets and missing transverse momentum from the undetected neutrino. No evidence for an FCNC signal was found. An upper limit on the t -> Zq branching ratio of BR(t -> Zq) < 0.73% is set at the 95% confidence level.